文献速递免疫规划传染病防控与疫情报告

使用病例对照研究设计比较两种对照组估计口服霍乱疫苗效果

Comparison of two control groups for estimation of oral cholera vaccine effectiveness using a case-control study design.
PubMed 文献 · Vaccine · 2017-09-12

在2012年10月至2016年11月海地农村的霍乱治疗中心,比较社区对照与检测阴性对照估计口服霍乱疫苗效果(VE)。两种对照估计的两剂自报接种VE一致且具统计学显著性,范围为72%至74%;偏倚指示分析提示社区对照可能高估VE,但检测阴性分析显示该偏倚若存在也很小。

要点

  • 两剂自报接种VE在社区对照与检测阴性对照间一致,具统计学显著性,范围为72%至74%。
  • 偏倚指示分析VE估计范围为19%至43%,部分具统计学显著性,提示社区对照可能高估VE。
  • 检测阴性对照可作为低成本、省时的有效替代,尤其在紧急情况下可能特别相关。

核心结论

  • 使用社区对照和检测阴性对照的病例对照分析所得口服霍乱疫苗效果估计相似。
  • 偏倚指示分析提示使用社区对照可能高估VE估计,但检测阴性分析提示该偏倚若存在也很小。
  • 检测阴性对照可作为口服霍乱疫苗效果估计的有效、低成本且省时的替代对照,尤其在紧急情况下可能特别相关。

研究设计与样本

  • 研究于2012年10月至2016年11月在海地农村霍乱治疗中心招募急性水样腹泻患者。
  • 霍乱病例为粪便培养阳性;非霍乱腹泻病例(检测阴性对照及偏倚指示分析的非霍乱腹泻病例)为培养和快速检测阴性。
  • 按年龄组、时间和社区为每例腹泻病例匹配最多四名社区对照。

主要发现

  • 主要分析纳入181例霍乱病例、157例非霍乱腹泻病例、716名VE社区对照和625名偏倚指示社区对照。
  • 两剂自报接种VE在两种对照间一致,具统计学显著性的VE估计范围为72%至74%。
  • 敏感性分析显示两剂自报接种VE估计相似但有所减弱。
  • 偏倚指示分析VE估计始终小于一,范围为19%至43%,其中部分具统计学显著性。

临床怎么用

  • 作者认为检测阴性对照可作为社区对照的有效、低成本且省时的替代,用于口服霍乱疫苗效果估计,尤其在紧急情况下可能特别相关。

局限性

  • 偏倚指示分析提示使用社区对照可能高估VE估计。
  • 检测阴性分析提示该偏倚若存在也很小。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Case-control studies to quantify oral cholera vaccine effectiveness (VE) often rely on neighbors without diarrhea as community controls. Test-negative controls can be easily recruited and may minimize bias due to differential health-seeking behavior and recall. We compared VE estimates derived from community and test-negative controls and conducted bias-indicator analyses to assess potential bias with community controls. METHODS: From October 2012 through November 2016, patients with acute watery diarrhea were recruited from cholera treatment centers in rural Haiti. Cholera cases had a positive stool culture. Non-cholera diarrhea cases (test-negative controls and non-cholera diarrhea cases for bias-indicator analyses) had a negative culture and rapid test. Up to four community controls were matched to diarrhea cases by age group, time, and neighborhood. RESULTS: Primary analyses included 181 cholera cases, 157 non-cholera diarrhea cases, 716 VE community controls and 625 bias-indicator community controls. VE for self-reported vaccination with two doses was consistent across the two control groups, with statistically significant VE estimates ranging from 72 to 74%. Sensitivity analyses revealed similar, though somewhat attenuated estimates for self-reported two dose VE. Bias-indicator estimates were consistently less than one, with VE estimates ranging from 19 to 43%, some of which were statistically significant. CONCLUSIONS: OCV estimates from case-control analyses using community and test-negative controls were similar. While bias-indicator analyses suggested possible over-estimation of VE estimates using community controls, test-negative analyses suggested this bias, if present, was minimal. Test-negative controls can be a valid low-cost and time-efficient alternative to community controls for OCV effectiveness estimation and may be especially relevant in emergency situations.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Franke MF, Jerome JG, Matias WR, et al. Comparison of two control groups for estimation of oral cholera vaccine effectiveness using a case-control study design. Vaccine. 2017. PMID: 28916247. doi:10.1016/j.vaccine.2017.09.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。